Indication
Bondranat is used in prevention and treatment of osteoporosis, osteitisdeformans (“Paget’s disease of bone”), bone metastasis (with or without hypercalcaemia), multiple myeloma, primary hyperparathyroidism, osteogenesisimperfecta, fibrous dysplasia, and other conditions that feature bone fragility.
Note
Precaution
- Hypocalcaemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Bondronat therapy for metastatic bone disease.
- Adequate intake of calcium and vitamin D is important in all patients. Patients should receive supplemental calcium and/or vitamin D if dietary intake is inadequate.
- Bondronat is a prescription drug and should be used under proper medical guidance and advice.
